Stifel Financial’s Filana Therapeutics FLNA Stock Holding History

Stifel Financial’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-87,175	Closed	-$2.45M	–	3372
2022 Q2	$2.45M	Sell	87,175 -2,872	-3%	-$72.5K	﹤0.01%	1370
2022 Q1	$3.34M	Buy	90,047 +1,402	+2%	+$59.4K	﹤0.01%	1278
2021 Q4	$3.87M	Buy	88,645 +33,978	+62%	+$1.78M	0.01%	1211
2021 Q3	$3.39M	Sell	54,667 -4,511	-8%	-$376K	0.01%	1241
2021 Q2	$5.06M	Buy	59,178 +4,300	+8%	+$230K	0.01%	1024
2021 Q1	$2.47M	Buy	+54,878	New	+$2.16M	﹤0.01%	1386

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial's FLNA Position: Q3 2022 in Review

Stifel Financial sold out of Filana Therapeutics (FLNA) in Q3 2022, closing a stake of 87,175 shares — an estimated $2.45M sold.

Stifel Financial first reported a position in FLNA in Q1 2021 and held it in 6 quarters. The position peaked at $5.06M in Q2 2021. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

Stifel Financial reported no remaining Filana Therapeutics position as of Q3 2022 after selling out during the quarter.
Stifel Financial sold 87,175 Filana Therapeutics shares in Q3 2022, an estimated $2.45M.
Stifel Financial first reported a position in Filana Therapeutics in Q1 2021 and held it in 6 quarters.
Stifel Financial's Filana Therapeutics position peaked at $5.06M in Q2 2021.
175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on Stifel Financial's 13F filing for Q3 2022, filed 14 Nov 2022.